The order, which amounted to over $6,000, included 30 tests ...

The company that brought back the dire wolf is launching a new biovault to store the genomes of the most at-risk species.

The NMPA has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic medical device in China.

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the first public showcase of QIAsprint Connect at SLAS 2026 in Boston, marking QIAGEN’s entry into high-throughput benchtop ...